Drug and pharmaceutical recalls
709 federal recalls in the last 12 months. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.
- 2026-02-04FDA-DrugNOVADOZ PHARMACEUTICALS LLCClass IIIStop using recalled Novadoz glycopyrrolate solution
Novadoz Pharmaceuticals is recalling specific lots of glycopyrrolate oral solution (1 mg/5 mL) because the medication failed quality testing for impurities and degradation. The affected lots may not meet safety and effectiveness standards. Three lots are involved, with expiration dates between April and May 2027.
- 2026-02-04FDA-DrugGreenstone LlcClass IIStop using Greenstone methylprednisolone Dosepak
Greenstone LLC is recalling methylprednisolone 4 mg Dosepak tablets (Lot #LG7675, expiring November 2026) because the blister foil is oriented incorrectly. This misalignment can make the dosing directions on the foil confusing or unclear, which could lead to taking the wrong dose.
- 2026-02-04FDA-DrugSato Pharmaceutical Co., LtdClass IIStop using Sato INON ACE antacid tablets
Some bottles of INON ACE antacid tablets are dissolving more slowly than they should in your stomach. This means the medication may not work as intended. The affected bottles were distributed in California and Hawaii.
- 2026-02-04FDA-DrugHaleon US Holdings LLCClass IIICheck your Parodontax mouthwash lot number
Some bottles of Parodontax Active Gum Health mouthwash (mint, 16.9 FL OZ) may be missing or have illegible lot and expiration date codes. This makes it impossible to know when the product expires. The affected lot is #0665363 with an expiration date of 08/31/2027.
- 2026-02-04FDA-DrugBaxter Healthcare CorporationClass IIStop using Baxter Sterile Water for Irrigation
Baxter Healthcare's Sterile Water for Irrigation 250 mL bottles may contain small plastic particles that came loose from the bottle rim and entered the solution. This affects lot G171359 with an expiration date of 05/31/2027. No injuries have been reported.
- 2026-01-28FDA-DrugZydus Pharmaceuticals (USA) IncClass IIStop using Zydus Icosapent Ethyl capsules
Zydus Pharmaceuticals is recalling Icosapent Ethyl 1-gram capsules because some bottles may contain capsules that have lost potency (strength) due to leakage and oxidation. This means the medication may not work as intended. The recall affects specific lot numbers expiring in February and April 2027.
- 2026-01-28FDA-DrugSpecialty Process Labs LLCClass IIStop using Specialty Process Labs Thyroid USP
Specialty Process Labs is recalling one lot of Thyroid, USP (an active pharmaceutical ingredient used in manufacturing) because it does not meet strength standards. The affected lot may contain less active ingredient than labeled, which could affect the potency of products made with it.
- 2026-01-28FDA-DrugGraviti Pharmaceuticals Private LimitedClass IIStop using Rising Pharmaceuticals Furosemide tablets
Rising Pharmaceuticals is recalling Furosemide Tablets, USP 40 mg (a water pill used to treat swelling and high blood pressure) because some bottles may contain a foreign substance. The affected lot is FUB125042G with an expiration date of May 2027. This recall affects 4,212 bottles distributed nationwide.
- 2026-01-28FDA-DrugCipla USA, Inc.Class IIIStop using Cipla Diclofenac Sodium Topical Gel
Cipla USA is recalling Diclofenac Sodium Topical Gel 1% (batch XHBG, expiring 08/31/2027) because it failed to meet required pH specifications during quality testing. The gel may not work as intended or could cause skin irritation. No injuries have been reported so far.
- 2026-01-21FDA-DrugCipla USA, Inc.Class IIStop using Cipla Lanreotide Injection
Cipla USA is recalling certain pre-filled syringes of Lanreotide Injection 120 mg because they may contain particulate matter (small particles) in the solution. The affected syringes have specific lot numbers and expiration dates between October 2026 and March 2027. No injuries have been reported so far.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IIStop using recalled Colgate and Crest toothpaste
Several Colgate and Crest toothpaste products distributed by Gold Star Distribution Inc. were stored in conditions with rodent exposure and activity. The FDA found insanitary conditions at the distribution center that do not meet manufacturing standards. No injuries have been reported.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IICheck your Axe and Lucky deodorants
Gold Star Distribution Inc. distributed multiple Axe body sprays and Lucky deodorant products that were stored in conditions with rodent activity. The FDA found insanitary handling at their distribution center. No injuries have been reported.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IIStop using recalled petroleum jelly products
Gold Star Distribution Inc. distributed several petroleum jelly products that were stored in insanitary conditions, including exposure to rodents, at their distribution center. The affected products include Vaseline, Lucky, Personal Care, and Softee petroleum jelly in various sizes and formulations. All lots distributed by Gold Star that have not expired may be affected.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IIStop using Lucky Ice Cool Mouthwash
Lucky Ice Cool Mouthwash was distributed from a facility with insanitary conditions, including rodent exposure and activity. The FDA is recalling all unexpired lots of this product due to potential contamination from the distribution center conditions.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IIStop using Gold Star vaporizing chest rub
Gold Star Distribution's 4 oz vaporizing chest rub was distributed from a facility with insanitary conditions, including rodent exposure. The product may have been contaminated during storage or handling at their distribution center.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IIStop using Carmex lip balm jars and tubes
Carmex lip balm products distributed by Gold Star Distribution Inc. were stored in conditions with rodent exposure and activity. The products may have been affected by insanitary conditions at their distribution center. This recall affects jars and tubes sold nationwide.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IIStop using Gold Star Distribution ice gel
Gold Star Distribution's 8oz ice gel products were stored in conditions where rodents were present in their distribution center. The FDA found insanitary conditions that do not meet required manufacturing and distribution standards. All unexpired lots distributed by this company are affected.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IIStop using Swan White Clear Alcohol
Swan White Clear Alcohol (50%, 16oz bottles) distributed by Gold Star Distribution Inc. was stored in conditions with rodent exposure and activity, along with other sanitation violations. This affected all lots still within expiration across the U.S.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IIStop using recalled TUMS antacid tablets
TUMS antacid tablets distributed by Gold Star Distribution Inc. were stored in conditions with rodent exposure at their distribution center. This applies to TUMS Assorted 12-count, Extra Strength Assorted Berries 12-count (#1194A, dated 05/27), and Extra Strength Assorted Fruit 12-count (#1194C, dated 03/27) sold nationwide. No injuries have been reported.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IIStop using Halls Cough Drops
Halls Cough Drops distributed by Gold Star Distribution Inc. were stored in conditions with rodent exposure and activity at their distribution center. This creates a potential contamination risk. The recall affects multiple flavors and package sizes distributed nationwide.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IIStop using recalled Tylenol products
Several Tylenol products distributed by Gold Star Distribution Inc. were stored in conditions where rodents were present at their distribution center. This poses a potential contamination risk. The recall affects multiple Tylenol formulations including 500 mg, Cold & Flu, Cold & Flu Severe, PM, and Sinus Severe products nationwide.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IIStop using Pepcid Complete 25ct tablets
Pepcid Complete 25-count packages distributed by Gold Star Distribution Inc. were stored in conditions with rodent activity and other sanitary issues at their distribution center. This affects all unexpired lots distributed nationwide by this company.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IIStop using Pepto Bismol from Gold Star Distribution
Pepto Bismol 32-count packs distributed by Gold Star Distribution Inc. were stored in conditions that included rodent exposure and activity. The distributor did not maintain proper sanitation standards required for over-the-counter medicines. All lots still within expiration date are affected.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IIStop using Children's Nyquil Cold & Flu
Children's Nyquil Cold & Flu (Berry flavor, 8 oz bottles) distributed by Gold Star Distribution has been recalled due to insanitary conditions, including rodent activity, found in their distribution center. All unexpired lots distributed by this company are affected. No injuries have been reported.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IIStop using NyQuil Cold & Flu from Gold Star
NyQuil Cold & Flu products distributed by Gold Star Distribution Inc. were stored in conditions with rodent activity and other sanitation issues. The FDA has recalled all affected lots that are still within their expiration date.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IIStop using recalled Liquid NyQuil products
Gold Star Distribution Inc. distributed Liquid NyQuil (regular and cherry varieties) from a facility with insanitary conditions, including evidence of rodent activity. The affected products were distributed nationwide and remain on store shelves.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IIStop using Motrin 2's Dispenser 50-count
Gold Star Distribution Inc. distributed Motrin 2's Dispenser 50-count packages that were stored in conditions with rodent exposure and activity. The FDA found insanitary conditions at their distribution center that violated manufacturing safety standards.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IIStop using recalled Excedrin Migraine 2's
Excedrin Migraine 2's distributed by Gold Star Distribution Inc. were stored in conditions with rodent exposure and activity at their distribution center. This poses a potential contamination risk. All affected lots that are still within their expiration date are included in this recall.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IICheck your Excedrin 2's for potential contamination
Excedrin 2's pain reliever tablets distributed by Gold Star Distribution have been recalled due to insanitary conditions found at their distribution center, including evidence of rodent activity. All unexpired batches distributed by this company are affected. No injuries have been reported so far.
- 2026-01-21FDA-DrugGOLD STAR DISTRIBUTION INCClass IIStop using recalled DayQuil liquid
DayQuil liquid (12/8oz bottles) distributed by Gold Star Distribution Inc. was stored in conditions that did not meet safety standards, including exposure to rodents at their distribution center. All unexpired lots distributed by this company are affected. No injuries have been reported.
Get notified about new drug recalls
Free weekly digest. We email when a new federal recall in this category — or anything else affecting your household — is published.